Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 17, 2014 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma to Present at the Noble Financial Capital Markets "X" Tenth Annual Equity Conference

PORTLAND, Ore., Jan. 17, 2014 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major...
January 14, 2014 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma and Dr. Reddy's Announce Strategic Partnership for NeuVax(TM) in India

Galena licenses commercial rights to Dr. Reddy's for NeuVax™ (nelipepimut-S) in breast and gastric cancers Dr. Reddy's to lead the development of NeuVax in Gastric Cancer, significantly...
January 13, 2014 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Acquires Mills Pharmaceuticals, LLC

Acquisition adds GALE-401 (Anagrelide CR) to expand Galena's product pipeline. Phase 2 clinical trial expected to begin in mid-2014 with GALE-401 to treat Essential Thrombocythemia (ET), an...
January 07, 2014 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Enrolls First Patient in GALE-301 (Folate Binding Protein (FBP)) Cancer Immunotherapy Phase 2 Clinical Trial in Ovarian Cancer

PORTLAND, Ore., Jan. 7, 2014 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major...
December 04, 2013 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma to Present at the Oppenheimer 24th Annual Healthcare Conference

PORTLAND, Ore., Dec. 4, 2013 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major...
November 26, 2013 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma to Present at the 25th Annual Piper Jaffray Healthcare Conference

PORTLAND, Ore., Nov. 26, 2013 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major...
November 11, 2013 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Announces Initial Results From the Folate Binding Protein Vaccine Phase 1 Trial at the Society for Immunotherapy of Cancer Conference

Folate Binding Protein (FBP) shown to be safe and immunogenic in its Phase 1 trial Phase 2a trial expected to initiate by year end PORTLAND, Ore., Nov. 11, 2013 (GLOBE NEWSWIRE) -- Galena...
November 06, 2013 16:35 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Reports Third Quarter 2013 Results

PORTLAND, Ore., Nov. 6, 2013 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biopharmaceutical company commercializing and developing innovative, targeted oncology treatments that address major...
October 07, 2013 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Announces Oral Presentation at the American College of Surgeons Clinical Congress 2013

NeuVax induces a full immune response in treated patients and creates an immune memory to target residual cancer cells Phase 3 PRESENT HER2 1+/2+ patients confirmed as optimal treatment...
October 04, 2013 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma to Present at the 12th Annual BIO Investor Forum

PORTLAND, Ore., Oct. 4, 2013 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major...